SPINEREP granted "Breakthrough Device Designation” by the U.S. Food and Drug Administration

NeuroBioMat's polymer medical device, SPINEREP, which is indicated to treat traumatic non-penetration spinal cord injury, has been granted "Breakthrough Device Designation” by the U.S. Food and Drug Administration as a technological breakthrough. This award provides access to the FDA's new program which aims at facilitating quicker and more direct passage for critically ill patients to novel medical devices of this kind.